ReShape Lifesciences Inc. (NASDAQ:RSLS), formerly EnteroMedics Inc., is a medical device company focused on the development of minimally invasive medical devices to treat obesity and metabolic diseases. ReShape Lifesciences™ is committed to the delivery of safe, effective, and sustainable obesity solutions. The company is rapidly advancing its innovative technologies to broadly benefit patients, healthcare providers, and stakeholders around the world.